Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Kiyoi

Showing results (11-20 of 270) with videos related to

Pageof 27
Sort By:
International Journal of Hematology|May 14, 2013
Guest editorial: efficacy of and resistance to molecularly targeted therapy for myeloid malignanciesHitoshi Kiyoi
Nagoya Journal of Medical Science|March 16, 2023
A never-ending FLT3 storyHitoshi Kiyoi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 2, 2006
[Possibility of targeting FLT3 kinase for the treatment of leukemia]Hitoshi Kiyoi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 17, 2013
[Leukemia: recent progress in diagnosis and treatment. Topics: III. Diagnosis and treatments; 3. Treatment for acute promyelocytic leukemia]Hitoshi Kiyoi
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 9, 2012
[Molecularly target therapy]Hitoshi Kiyoi
Oncology|November 10, 2015
Overview: A New Era of Cancer Genome in Myeloid MalignanciesHitoshi Kiyoi
International Journal of Hematology|January 30, 2013
Gene mutations of acute myeloid leukemia in the genome eraTomoki Naoe, Hitoshi Kiyoi
Leukemia & Lymphoma|October 29, 2002
FLT3 in human hematologic malignanciesHitoshi Kiyoi, Tomoki Naoe
Methods in Molecular Medicine|March 1, 2006
FLT3 mutations in acute myeloid leukemiaHitoshi Kiyoi, Tomoki Naoe
International Journal of Hematology|June 8, 2006
Biology, clinical relevance, and molecularly targeted therapy in acute leukemia with FLT3 mutationHitoshi Kiyoi, Tomoki Naoe
Pageof 27

Showing results (11-20 of 270) with videos related to

Sort By:
Pageof 27
International Journal of Hematology|May 14, 2013
Guest editorial: efficacy of and resistance to molecularly targeted therapy for myeloid malignanciesHitoshi Kiyoi
Nagoya Journal of Medical Science|March 16, 2023
A never-ending FLT3 storyHitoshi Kiyoi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 2, 2006
[Possibility of targeting FLT3 kinase for the treatment of leukemia]Hitoshi Kiyoi
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 17, 2013
[Leukemia: recent progress in diagnosis and treatment. Topics: III. Diagnosis and treatments; 3. Treatment for acute promyelocytic leukemia]Hitoshi Kiyoi
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 9, 2012
[Molecularly target therapy]Hitoshi Kiyoi
Oncology|November 10, 2015
Overview: A New Era of Cancer Genome in Myeloid MalignanciesHitoshi Kiyoi
International Journal of Hematology|January 30, 2013
Gene mutations of acute myeloid leukemia in the genome eraTomoki Naoe, Hitoshi Kiyoi
Leukemia & Lymphoma|October 29, 2002
FLT3 in human hematologic malignanciesHitoshi Kiyoi, Tomoki Naoe
Methods in Molecular Medicine|March 1, 2006
FLT3 mutations in acute myeloid leukemiaHitoshi Kiyoi, Tomoki Naoe
International Journal of Hematology|June 8, 2006
Biology, clinical relevance, and molecularly targeted therapy in acute leukemia with FLT3 mutationHitoshi Kiyoi, Tomoki Naoe
Pageof 27